United States · FDA National Drug Code directory
Rhophylac
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 44206-300_32c1f783-bd20-45bc-98d8-cdd5efa9f0d6
- Product NDC
- 44206-300
- Form
- SOLUTION
- Composition / generic term
- HUMAN RHO(D) IMMUNE GLOBULIN
- Labeler
- CSL Behring AG
- Marketing category
- BLA
- Marketing start / end (source format)
- 20090106
- Source listing expiry
- 20261231
Source-listed ingredients
- HUMAN RHO(D) IMMUNE GLOBULIN — 1500 [iU]/2mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 SYRINGE, GLASS in 1 CARTON (44206-300-01) / 2 mL in 1 SYRINGE, GLASS (44206-300-90) · 44206-300-01
- 10 SYRINGE, GLASS in 1 CARTON (44206-300-10) / 2 mL in 1 SYRINGE, GLASS (44206-300-90) · 44206-300-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →